Virginia Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 17 (65% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 6,134
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 31.36%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 1,814
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 36.63%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 65.54% 60.47%
White, Hispanic/Latino Patients 4.01% 5.84%
Black/African American, Non-Hispanic/Latino Patients 21.16% 24.59%
Black/African American, Hispanic/Latino Patients 0.51% 0.28%
Asian Patients3 0.75% 0.61%
American Indian/Alaska Native Patients3 0.33% 0.28%
Native Hawaiian/Other Pacific Islander Patients3 0.11% 0.11%
Patients with More Than One Race3 1.47% 1.38%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.61% 1.87%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.86% 0.94%
Unreported/Refused to Report Race and Ethnicity 3.65% 3.64%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 319
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 69.23%
COVID-19 Immunization Series Completed 247
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 73.88%
COVID-19 Immunization Series Additional 1,133
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 50.81%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 30.09% 25.91% 48.54%
White, Hispanic/Latino Patients 43.26% 50.20% 19.77%
Black/African American, Non-Hispanic/Latino Patients 16.61% 14.17% 20.48%
Black/African American, Hispanic/Latino Patients 0.31% 0.00% 0.35%
Asian Patients3 2.82% 2.83% 1.15%
American Indian/Alaska Native Patients3 1.57% 0.00% 4.06%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.81% 0.18%
Patients with More Than One Race3 0.00% 0.40% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.13% 4.86% 4.15%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.25% 0.40% 0.44%
Unreported/Refused to Report Race and Ethnicity 0.94% 0.40% 0.88%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 11.76%
1 to 24 Hours 23.53%
More Than 24 Hours 64.71%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 41.18%
Vaccine confidence 29.41%
Vaccine storage capacity 0.00%
Vaccine supply 5.88%
Other 5.88%
None 23.53%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 35.29%
Average Percent of Health Center Visits Conducted Virtually 10.88%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 35.29%
Number of Mobile Van Sites 13
Number of Pop-up Clinics 1
Number of School-Based Vaccination Sites 1
Number of Family Vaccination Clinics 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 35.29%
None 64.71%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 23.53%
Patient awareness/education 5.88%
Staffing capacity 17.65%
Therapy administration/onsite logistics 11.76%
Other 11.76%
None 35.29%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 2
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 245

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 50.00%
Provide to General Public Who Came to the Health Center 0.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 50.00%
Other 50.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022